A WHO official, ‘The TAG met on October 26, 2021, and decided to seek additional clarifications from the Covaxin manufacturers that are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine’
Covaxin likely to get emergency approval after WHO committee’s meeting today - Covaxin is likely to get the emergency use approval by WHO today after the meeting of the technical advisory committee.
Covaxin trial volunteer died of suspected poisoning, clarifies Bharat Biotech
Bharat Biotech revealed that one of the participants for Phase III trials passed away on December 21, 2020, and the death was reported to the People s College of Medical Sciences and Research Centre by the son of the deceased
BusinessToday.In | January 10, 2021 | Updated 03:36 IST
After a volunteer for Covaxin trials in Bhopal was reported dead, manufacturer Bharat Biotech has clarified that the subject met all the inclusion and exclusion criteria required to be accepted as a participant in the Phase III trial. The company further added that the participant was reported to be healthy in all the site follow up calls post seven days of his dosing.
Disgraceful to politicise such critical issue : Vardhan to oppn on Covid vaccine efficacy
Premium
Union Health Minister Harsh Vardhan visits Guru Teg Bahadur Hospital to review the dry run drill for administering COVID-19 vaccine, in New Delhi
(PTI)
Regarding the phase 3 trials of Covaxin and the vaccine s available data so far, Harsh Vardhan said, There were no seroconversions in those who were provided vaccines in Phase II as well as Phase I of COVAXIN clinical trials
Calling out a number of opposition leaders, Vardhan said that it is disgraceful for anyone to politicise such a critical issue
Share Via
Read Full Story